Table 1.
Clinical and Histopathologic Data.
| Total (n = 56) | Low hTERT (n = 17) | Not Detectable hTERT (n = 33) | High hTERT (n = 6) | Patients at Follow-up | ||
| Alive* (n = 6) | Dead† (n = 50) | |||||
| Men/Women | 36:20 | 11:6 | 20:13 | 5:1 | 4:2 | 32:18 |
| Tumor stage | ||||||
| I | 2 | 1 | 1 | 0 | 1 | 1 |
| II | 12 | 2 | 8 | 2 | 1 | 11 |
| III | 31 | 7 | 21 | 3 | 4 | 27 |
| IV | 11 | 7 | 3 | 1 | 0 | 11 |
| Tumor resection | ||||||
| Radical (R0) | 38 | 9 | 25 | 4 | 5 | 33 |
| Not radical (R1) | 9 | 2 | 6 | 1 | 1 | 8 |
| Not radical (R2) | 9 | 6 | 2 | 1 | 0 | 9 |
| Patients at follow-up | ||||||
| Alive* | 6 | 0 | 5 | 1 | 6 | |
| Dead† | 50 | 17 | 28 | 5 | 50 | |
Data are number of patients.
*
After an average observation time of 15.8 months (range, 1–61 months).
†
Patients died after an average of 14 months (range, 1–49 months), 2 patients died of non-tumor-related reasons.